Investment
Features
FeesSafety
Academy
More
Pluang+

Compare DuPont de Nemours Inc (DD) vs Verisign, Inc. (VRSN) Price & Performance

DuPont de Nemours IncTrade
Verisign, Inc.Trade

Price performance (Past 24H)

Key statistics

DuPont de Nemours Inc vs Verisign, Inc. — how do they compare? DuPont de Nemours Inc trades at $131.75 (market cap $17.89B), while Verisign, Inc. trades at $297.8 (market cap $26.92B). The key difference: Verisign, Inc. is the larger of the two by market cap, and DuPont de Nemours Inc pays the higher dividend (1.81%). Which is the better fit depends on your goals — on Pluang, investors hold DuPont de Nemours Inc for 89 Days and Verisign, Inc. for 123 Days on average.

DDVRSN
Market Cap
$17.89B$26.92B
Volume
816,4091,921,402
Sector
Basic MaterialsTechnology
52-Week High
$154.59$310.00
52-Week Low
$92.49$211.49
Typical Hold Time
89 Days123 Days
Enterprise Value
$19.28B$28.23B
Dividend Yield
1.81%1.09%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

DuPont de Nemours Inc

DuPont (DD) trades at $131.08, down 1.65% on the day, with neutral technical signals from moving averages and oscillators. The company shows mixed fundamentals with recent earnings beats but declining revenue from $12.4B in 2024 to $6.85B in 2025, resulting in a net loss of $779M. Analyst sentiment remains positive with 58.5% buy ratings, though the consensus price target of $95 suggests caution. Recent developments include new product launches in sugar separation technology and Tyvek innovations, alongside ongoing PFAS litigation settlements.

The outlook for DD hinges on margin recovery and growth in key sectors like healthcare and water technologies, but investors face risks from legal liabilities, volatile cash flows, and high P/E valuation. Institutional activity shows mixed signals with both position reductions and significant increases, reflecting uncertainty about near-term performance amid structural growth opportunities.

Verisign, Inc.

VeriSign (VRSN) trades at $294.22, up 0.38% on the day, with a bullish technical outlook supported by moving averages and a consensus analyst price target of $348. The company reported strong 2025 results with $1.66 billion in revenue and a net income margin near 50%, though recent quarterly EPS results have been mixed. Positive sentiment is driven by record domain registrations and institutional buying, while an antitrust lawsuit presents a notable risk.

The stock offers upside potential based on analyst targets, supported by stable cash flow and high profitability. Key risks include legal challenges and competitive pressures. The upcoming Q3 2026 earnings report on October 22 will be critical for validating growth expectations.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

DD

No sentiment data available yet.

VRSN
89% Buy11% Sell
Avg holding period · 123 Days

Top news

Latest headlines on both assets

About DuPont de Nemours Inc

DuPont is a diversified global specialty chemicals company created in 2019 as a result of the DowDuPont merger and subsequent separations. Its portfolio includes specialty chemicals and downstream products that serve the electronics and communication, automotive, construction, safety and protection, and water management industries. DuPont benefits from the ability to produce patented specialty chemicals that command pricing power. Noteworthy products include Kevlar, Tyvek, and Nomex have evolved over time to enable a wide range of applications across multiple industries.

Read more on DD →

About Verisign, Inc.

Verisign is the sole authorized registry for several generic top-level domains, including the widely utilized .com and .net top-level domains. The company operates critical Internet infrastructure to support the domain name system, including operating two of the world's 13 root servers that are used to route Internet traffic. In 2018, the firm sold off its Security Services business, signalling a renewed focus on the core registry business.

Read more on VRSN →